Pharmacometrics Research Group, Department of Pharmaceutical Biosciences, Uppsala University, Box 591, SE 751 24, Uppsala, Sweden.
J Pharmacokinet Pharmacodyn. 2012 Oct;39(5):453-62. doi: 10.1007/s10928-012-9261-5. Epub 2012 Jul 31.
Despite the impact of red blood cell (RBC) Life-spans in some disease areas such as diabetes or anemia of chronic kidney disease, there is no consensus on how to quantitatively best describe the process. Several models have been proposed to explain the elimination process of RBCs: random destruction process, homogeneous life-span model, or a series of 4-transit compartment model. The aim of this work was to explore the different models that have been proposed in literature, and modifications to those. The impact of choosing the right model on future outcomes prediction--in the above mentioned areas--was also investigated. Both data from indirect (clinical data) and direct life-span measurement (biotin-labeled data) methods were analyzed using non-linear mixed effects models. Analysis showed that: (1) predictions from non-steady state data will depend on the RBC model chosen; (2) the transit compartment model, which considers variation in life-span in the RBC population, better describes RBC survival data than the random destruction or homogenous life-span models; and (3) the additional incorporation of random destruction patterns, although improving the description of the RBC survival data, does not appear to provide a marked improvement when describing clinical data.
尽管红细胞 (RBC) 寿命在某些疾病领域(如糖尿病或慢性肾脏病贫血)中有影响,但如何定量最佳地描述该过程仍未达成共识。已经提出了几种模型来解释 RBC 的消除过程:随机破坏过程、均匀寿命模型或一系列 4 转移隔室模型。本工作旨在探讨文献中提出的不同模型及其改进。还研究了选择正确模型对上述领域未来结果预测的影响。间接(临床数据)和直接寿命测量(生物素标记数据)方法的数据均使用非线性混合效应模型进行分析。分析表明:(1)非稳态数据的预测将取决于所选择的 RBC 模型;(2)考虑 RBC 群体中寿命变化的转移隔室模型比随机破坏或均匀寿命模型更好地描述 RBC 生存数据;(3)尽管添加随机破坏模式可以改善 RBC 生存数据的描述,但在描述临床数据时似乎并没有显著改善。